Delivery Order SPE2DB20D1100-SPE2DB25FB3Y8

Award Date 3/27/25
Potential Completion Date 4/17/25
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,915.42 firm fixed-price delivery order contract is for the supply of IMFINZI 500 MG/10 ML VIAL 10ML, a specialty pharmaceutical product. The contract has an ultimate completion date of February 27, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,957.71 firm fixed-price delivery order is for the supply of IMFINZI 500 MG/10 ML VIAL 10ML, a medical product. The contract has an ultimate completion date of March 10, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,957.71 firm-fixed-price delivery order is for IMFINZI 500 MG/10 ML VIAL 10ML, a pharmaceutical product, with a completion date of April 3, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,952.92 firm fixed-price delivery order contract is for the supply of IMFINZI 500 mg/10 ml vials, a specialty oncology medication. The contract has an ultimate completion date of December 27, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $59,529.12 firm fixed-price delivery order is for the medical product IMFINZI 500 MG/10 ML VIAL 10ML. The contract has an ultimate completion date of October 3, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract, valued at $15,420.00, is for the supply of IMFINZI 500 MG/10 ML VIAL 10ML, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999, for the delivery of a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of IMFINZI 500 MG/10 ML VIAL 10ML pharmaceutical products. The $20,560.00 firm-fixed-price contract has an ultimate completion date of October 17, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $60,233.28 firm fixed-price delivery order is for IMFINZI 500 MG/10 ML VIAL 10ML, with a completion date of July 14, 2023. The contract is not designated under any set-aside program, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This federal contract award, valued at $13,262.85, was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of IMFINZI 500 MG/10 ML VIAL 10ML, a pharmaceutical product, with a performance period extending until June 4, 2025. The contract is a Firm Fixed Price Delivery Order and is not set-aside. Amerisourcebergen Drug Corp is the prime contractor and holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,294.10 firm fixed-price delivery order is for 4566554698 - IMFINZI 500 MG/10 ML VIAL 10ML. The contract has an ultimate completion date of December 18, 2024. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FB3Y8
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,915.42 firm-fixed-price delivery order is for the medical product IMFINZI 500 MG/10 ML VIAL 10ML. The contract has an ultimate completion date of April 17, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition.

Generated 6/26/25, 9:56 AM